466 related articles for article (PubMed ID: 25609773)
21. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
Saito S; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Kuratani T; Sawa Y
J Heart Lung Transplant; 2010 Jun; 29(6):672-9. PubMed ID: 20188595
[TBL] [Abstract][Full Text] [Related]
22. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
Klotz S; Naka Y; Oz MC; Burkhoff D
J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
[TBL] [Abstract][Full Text] [Related]
23. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling.
Kato TS; Chokshi A; Singh P; Khawaja T; Cheema F; Akashi H; Shahzad K; Iwata S; Homma S; Takayama H; Naka Y; Jorde U; Farr M; Mancini DM; Schulze PC
Circ Heart Fail; 2011 Sep; 4(5):546-53. PubMed ID: 21765125
[TBL] [Abstract][Full Text] [Related]
24. Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study.
Patel SR; Saeed O; Murthy S; Bhatia V; Shin JJ; Wang D; Negassa A; Pullman J; Goldstein DJ; Maybaum S
J Heart Lung Transplant; 2013 Mar; 32(3):305-12. PubMed ID: 23415314
[TBL] [Abstract][Full Text] [Related]
25. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy.
Altemose GT; Gritsus V; Jeevanandam V; Goldman B; Margulies KB
J Heart Lung Transplant; 1997 Jul; 16(7):765-73. PubMed ID: 9257259
[TBL] [Abstract][Full Text] [Related]
26. Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure.
Kato TS; Chokshi A; Singh P; Khawaja T; Iwata S; Homma S; Akashi H; Cheema F; Yang J; Takayama H; Naka Y; Farr M; Mancini D; Schulze PC
J Heart Lung Transplant; 2012 Jan; 31(1):37-45. PubMed ID: 22071239
[TBL] [Abstract][Full Text] [Related]
27. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury.
Ahmad T; Wang T; O'Brien EC; Samsky MD; Pura JA; Lokhnygina Y; Rogers JG; Hernandez AF; Craig D; Bowles DE; Milano CA; Shah SH; Januzzi JL; Felker GM; Patel CB
JACC Heart Fail; 2015 Jan; 3(1):30-39. PubMed ID: 25447345
[TBL] [Abstract][Full Text] [Related]
28. Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device.
Mondal NK; Sorensen EN; Hiivala NJ; Feller ED; Pham SM; Griffith BP; Wu ZJ
Platelets; 2015; 26(6):536-44. PubMed ID: 25167344
[TBL] [Abstract][Full Text] [Related]
29. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
[TBL] [Abstract][Full Text] [Related]
30. Cell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure.
Farris SD; Don C; Helterline D; Costa C; Plummer T; Steffes S; Mahr C; Mokadam NA; Stempien-Otero A
J Am Coll Cardiol; 2017 Jul; 70(3):344-354. PubMed ID: 28705316
[TBL] [Abstract][Full Text] [Related]
31. Effect of Continuous-Flow Mechanical Circulatory Support on Microvasculature Remodeling in the Failing Heart.
Saito T; Miyagawa S; Toda K; Yoshikawa Y; Fukushima S; Saito S; Yoshioka D; Sakata Y; Daimon T; Sawa Y
Artif Organs; 2019 Apr; 43(4):350-362. PubMed ID: 30129970
[TBL] [Abstract][Full Text] [Related]
32. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
[TBL] [Abstract][Full Text] [Related]
33. Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.
Ichiki T; Schirger JA; Huntley BK; Brozovich FV; Maleszewski JJ; Sandberg SM; Sangaralingham SJ; Park SJ; Burnett JC
J Mol Cell Cardiol; 2014 Oct; 75():199-205. PubMed ID: 25117468
[TBL] [Abstract][Full Text] [Related]
34. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support.
Rodrigue-Way A; Burkhoff D; Geesaman BJ; Golden S; Xu J; Pollman MJ; Donoghue M; Jeyaseelan R; Houser S; Breitbart RE; Marks A; Acton S
J Heart Lung Transplant; 2005 Jan; 24(1):73-80. PubMed ID: 15653383
[TBL] [Abstract][Full Text] [Related]
35. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
36. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.
Jahanyar J; Joyce DL; Southard RE; Loebe M; Noon GP; Koerner MM; Torre-Amione G; Youker KA
J Heart Lung Transplant; 2007 Jan; 26(1):34-40. PubMed ID: 17234515
[TBL] [Abstract][Full Text] [Related]
37. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery.
Holzhauser L; Kim G; Sayer G; Uriel N
Curr Heart Fail Rep; 2018 Aug; 15(4):250-259. PubMed ID: 29971612
[TBL] [Abstract][Full Text] [Related]
39. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal structural, functional, and cellular myocardial alterations with chronic centrifugal continuous-flow left ventricular assist device support.
Muthiah K; Humphreys DT; Robson D; Dhital K; Spratt P; Jansz P; Macdonald PS; Hayward CS
J Heart Lung Transplant; 2017 Jul; 36(7):722-731. PubMed ID: 27373819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
